Effect of osmotic-release oral system methylphenidate on learning skills in adolescents with attention-deficit/hyperactivity disorder: An open-label study

International Clinical Psychopharmacology

Volumn 28, Issue 4, 2013, Pages 184-192

  Na, Kyoung Sae ^a   Lee, Soyoung Irene ^a   Hong, Sungdo David ⁱ   Kim, Ji Hoon ^b   Shim, Se Hoon ^a   Choi, Jeewook ^c   Yang, Jaewon ^e   Lee, Moon Soo ^f   Joung, Yoo Sook ^g   Kim, Eui Jung ^h   Park, Joon Ho ^d  

^a Soonchunhyang University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Daejeon St Mary's Hospital   (South Korea)

^d Daejeon University   (South Korea)

^e Department of Psychiatry   (South Korea)

^f Korea University College of Medicine   (South Korea)

^g Sungkyunkwan University School of Medicine   (South Korea)

^h Ewha Womans University School of Medicine   (South Korea)

ⁱ DEPARTMENT OF HEALTH   (Australia)

Author keywords

adolescents; attention deficit hyperactivity disorder; executive function; learning; methylphenidate

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DEFICIT DISORDER RATING SCALE; CHILD; CLINICAL GLOBAL IMPRESSION SCALE; DEPRESSION; DEPTH PERCEPTION; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RELEASE; EXECUTIVE FUNCTION; FATIGUE; FEMALE; HEADACHE; HUMAN; IRRITABILITY; LEARNING; LEARNING SKILLS TEST; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; NERVOUSNESS; OPEN STUDY; PERFORMANCE; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; STOMACH DISCOMFORT; STOMACH PAIN; STROOP TEST; TREATMENT DURATION; VERBAL MEMORY; VOMITING; WORKING MEMORY;

ADMINISTRATION, ORAL; ADOLESCENT; ANOREXIA; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DELAYED-ACTION PREPARATIONS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINE UPTAKE INHIBITORS; EXECUTIVE FUNCTION; FEMALE; HUMANS; INCIDENCE; INHIBITION (PSYCHOLOGY); LEARNING; LEARNING DISORDERS; MALE; MEMORY, SHORT-TERM; METHYLPHENIDATE; OSMOTIC PRESSURE; SPEECH DISORDERS;

EID: 84879895824     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e3283612509     Document Type: Article

References (65)

1. Adams W (2010). Wide-range assessment of memory and learning. The Corsini encyclopedia of psychology. New York: John Wiley & Sons Inc.
2. Atkinson TM, Konold TR, Glutting JJ (2008). Patterns of memory: a normative taxonomy of the Wide Range Assessment of Memory and Learning-Second Edition (WRAML-2). J Int Neuropsychol Soc 14:869-877.
3. Barbaresi WJ, Katusic SK, Colligan RC,Weaver AL, Jacobsen SJ (2007). Longterm school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. J Dev Behav Pediatr 28:265-273. (Pubitemid 47256029)
4. Barkley RA (1997). Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121:65-94. (Pubitemid 127705285)
5. Barkley RA, McMurray MB, Edelbrock CS, Robbins K (1990). Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 86:184-192. (Pubitemid 20238848)
6. Barkley RA, Fischer M, Smallish L, Fletcher K (2002). The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 111:279-289. (Pubitemid 34441206)
7. Barkley RA, Murphy KR (2005). Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. 3rd ed. New York: The Guilford Press.
8. Bauermeister JJ, Shrout PE, Ramirez R, Bravo M, Alegria M, Martinez-Taboas A, et al. (2007). ADHD correlates, comorbidity, and impairment in community and treated samples of children and adolescents. J Abnorm Child Psychol 35:883-898.
9. Bedard AC, Tannock R (2008). Anxiety, methylphenidate response, and working memory in children with ADHD. J Atten Disord 11:546-557.
10. Bedard AC, Ickowicz A, Tannock R (2002). Methylphenidate improves Stroop naming speed, but not response interference, in children with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 12:301-309. (Pubitemid 36169282)
11. Benton AL, Hamsher K (1989). Multilingual aphasia examination manual. Iowa: University of Iowa.
12. Biederman J, Faraone SV, Taylor A, Sienna M, Williamson S, Fine C (1998). Diagnostic continuity between child and adolescent ADHD: findings from a longitudinal clinical sample. J Am Acad Child Adolesc Psychiatry 37: 305-313. (Pubitemid 28101229)
13. Birchwood J, Daley D (2012). Brief report: the impact of attention deficit hyperactivity disorder (ADHD) symptoms on academic performance in an adolescent community sample. J Adolesc 35:225-231.
14. Byun YK, Kim SW (2006). Learning skills test. Seoul: Hakjisa Publisher.
15. Capano L, Minden D, Chen SX, Schacher RJ, Ickowicz A (2008). Mathematical learning disorder in school-age children with attention-deficit hyperactivity disorder. Can J Psychiatry 53:392-399. (Pubitemid 351878641)
16. Centers for Disease Control and Prevention (2010). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children-United States, 2003 and 2007. Atlanta, GA: Centers for Disease Control and Prevention. pp. 1439-1443.
17. Choong KC, Shen RY (2004). Methylphenidate restores ventral tegmental area dopamine neuron activity in prenatal ethanol-exposed rats by augmenting dopamine neurotransmission. J Pharmacol Exp Ther 309:444-451.
18. Daley D, Birchwood J (2010). ADHD and academic performance: why does ADHD impact on academic performance and what can be done to support ADHD children in the classroom? Child Care Health Dev 36:455-464.
19. Du Paul GJ, Power TJ, Anastopoulos AD, Reid R (1998). ADHD Rating Scale-IV: checklist, norms, and clinical interpretation. New York: Guilford Press.
20. Frazier TW, Youngstrom EA, Glutting JJ, Watkins MW (2007). ADHD and achievement: meta-analysis of the child, adolescent, and adult literatures and a concomitant study with college students. J Learn Disabil 40:49-65.
21. Gorman EB, Klorman R, Thatcher JE, Borgstedt AD (2006). Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45:808-816. (Pubitemid 43932907)
22. Guy W (1976). ECDEU Assessment Manual for Psychopharmacology-revised. Rockville, MD: US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs.
23. Hale JB, Reddy LA, Decker SL, Thompson R, Henzel J, Teodori A, et al. (2009). Development and validation of an attention-deficit/hyperactivity disorder (ADHD) executive function and behavior rating screening battery. J Clin Exp Neuropsychol 31:897-912.
24. Johansen EB, Killeen PR, Russell VA, Tripp G, Wickens JR, Tannock R, et al. (2009). Origins of altered reinforcement effects in ADHD. Behav Brain Funct 5:7.
25. Kang Y, Chin JH, Na DL, Lee J, Park JS (2000). A normative study of the Korean version of Controlled Oral Word Association Test (COWAT) in the elderly. Korean J Clin Psychol 19:385-392.
26. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. (1997). Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988. (Pubitemid 27272932)
27. Keulers EH, Hendriksen JG, Feron FJ, Wassenberg R, Wuisman-Frerker MG, Jolles J, et al. (2007). Methylphenidate improves reading performance in children with attention deficit hyperactivity disorder and comorbid dyslexia: an unblinded clinical trial. Eur J Paediatr Neurol 11:21-28. (Pubitemid 46076102)
28. Kieling C, Goncalves RR, Tannock R, Castellanos FX (2008). Neurobiology of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 17:285-307, viii. (Pubitemid 351258357)
29. Kim HK (2005).Kims frontal-executive function test for children: a manual. Daegu: Neuropsy.
30. Kim YS, So YK, Noh JS, Choi NK, Kim SJ, Koh YJ (2003). Normative data on the Korean ADHD Rating Scales (K-ARS) for patients and teacher. J Korean Neuropsychiatr Assoc 42:352-359.
31. Kim YS, Cheon KA, Kim BN, Chang SA, Yoo HJ, Kim JW, et al. (2004). The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version-Korean version (K-SADS-PL-K). Yonsei Med J 45:81-89. (Pubitemid 38372291)
32. Kwak KJ, Park HW, Kim CT (2002). A Study for the Standardization of Korean WISC-3 (1). Korean J Dev Psychol 15:19-33.
33. Langleben DD, Monterosso J, Elman I, Ash B, Krikorian G, Austin G (2006). Effect of methylphenidate on Stroop Color-Word task performance in children with attention deficit hyperactivity disorder. Psychiatry Res 141:315-320.
34. Liddle EB, Hollis C, Batty MJ, Groom MJ, Totman JJ, Liotti M, et al. (2011). Taskrelated default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate. J Child Psychol Psychiatry 52:761-771.
35. McGough JJ, McBurnett K, Bukstein O, Wilens TE, Greenhill L, Lerner M, et al. (2006). Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 16:351-356. (Pubitemid 43902431)
36. McInnes A, Humphries T, Hogg-Johnson S, Tannock R (2003). Listening comprehension and working memory are impaired in attention-deficit hyperactivity disorder irrespective of language impairment. J Abnorm Child Psychol 31:427-443. (Pubitemid 36773430)
37. Northup J, Fusilier I, Swanson V, Roane H, Borrero J (1997). An evaluation of methylphenidate as a potential establishing operation for some common classroom reinforcers. J Appl Behav Anal 30:615-625. (Pubitemid 127456074)
38. Pelham W (1993). Pharmacotherapy for children with attention-deficit hyperactivity disorder. Sch Psychol Rev 23:199-227.
39. Pietrzak RH, Mollica CM, Maruff P, Snyder PJ (2006). Cognitive effects of immediate-release methylphenidate in children with attention-deficit/ hyperactivity disorder. Neurosci Biobehav Rev 30:1225-1245. (Pubitemid 44855160)
40. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942-948. (Pubitemid 46972911)
41. Powers RL, Marks DJ, Miller CJ, Newcorn JH, Halperin JM (2008). Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome. J Child Adolesc Psychopharmacol 18: 449-459.
42. Purvis KL, Tannock R (2000). Phonological processing, not inhibitory control, differentiates ADHD and reading disability. J Am Acad Child Adolesc Psychiatry 39:485-494. (Pubitemid 30185544)
43. Rhodes SM, Coghill DR, Matthews K (2004). Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder. Psychopharmacology (Berl) 175:319-330. (Pubitemid 39361920)
44. Rubia K, Halari R, Cubillo A, Mohammad AM, Brammer M, Taylor E (2009). Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naive children with ADHD during a rewarded continuous performance task. Neuropharmacology 57:640-652.
45. Rucklidge JJ, Tannock R (2002). Neuropsychological profiles of adolescents with ADHD: effects of reading difficulties and gender. J Child Psychol Psychiatry 43:988-1003. (Pubitemid 36939277)
46. Sagvolden T, Aase H, Zeiner P, Berger D (1998). Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder. Behav Brain Res 94:61-71. (Pubitemid 28352465)
47. Scheffler RM, Brown TT, Fulton BD, Hinshaw SP, Levine P, Stone S (2009). Positive association between attention-deficit/hyperactivity disorder medication use and academic achievement during elementary school. Pediatrics 123:1273-1279.
48. Scheres A, Oosterlaan J, Swanson J, Morein-Zamir S, Meiran N, Schut H, et al. (2003). The effect of methylphenidate on three forms of response inhibition in boys with AD/HD. J Abnorm Child Psychol 31:105-120. (Pubitemid 36578355)
49. Semrud-Clikeman M (2005). Neuropsychological aspects for evaluating learning disabilities. J Learn Disabil 38:563-568. (Pubitemid 41730161)
50. Shin MS, Cho S, Chun SY, Hong K-EM (2000). A study of the development and standardization of ADHD diagnostic system. Korean J Child Adolesc Psychiatry 11:91-99.
51. So YK, Noh JS, Kim YS, Ko SG, Koh YJ (2002). The reliability and validity of Korean parent and teacher ADHD rating scale. J Korean Neuropsychiatr Assoc 41:283-289.
52. Solanto M, Newcorn J, Vail L, Gilbert S, Ivanov I, Lara R (2009). Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 19:663-671.
53. Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, et al. (2003). Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry 60:204-211. (Pubitemid 36173129)
54. Tannock R (1998). Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry 39:65-99. (Pubitemid 28059670)
55. Tripp G, Wickens JR (2008). Research review: dopamine transfer deficit: a neurobiological theory of altered reinforcement mechanisms in ADHD. J Child Psychol Psychiatry 49:691-704. (Pubitemid 351993219)
56. Tucha O, Lange KW (2001). Effects of methylphenidate on kinematic aspects of handwriting in hyperactive boys. J Abnorm Child Psychol 29:351-356. (Pubitemid 33745819)
57. Tucha O, Prell S, Mecklinger L, Bormann-Kischkel C, Kubber S, Linder M, et al. (2006). Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder. Psychopharmacology (Berl) 185:315-326.
58. Van der Oord S, Geurts HM, Prins PJ, Emmelkamp PM, Oosterlaan J (2012). Prepotent response inhibition predicts treatment outcome in attention deficit/hyperactivity disorder. Child Neuropsychol 18:50-61.
59. Verster JC, Bekker EM, Kooij JJ, Buitelaar JK, Verbaten MN, Volkerts ER, et al. (2010). Methylphenidate significantly improves declarative memory functioning of adults with ADHD. Psychopharmacology (Berl) 212:277-281.
60. Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, et al. (2004). Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry 161: 1173-1180. (Pubitemid 38859165)
61. Volkow ND,Wang GJ, Kollins SH,Wigal TL, Newcorn JH, Telang F, et al. (2009). Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 302:1084-1091.
62. Wechsler D (1991). The Wechsler intelligence scale for children-third edition. San Antonio: Psychological Corp.
63. Wigal SB, Wigal T, Schuck S, Brams M, Williamson D, Armstrong RB, et al. (2011). Academic, behavioral, and cognitive effects of OROS(R) methylphenidate on older children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 21:121-131.
64. Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, et al. (2006). Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 160:82-90. (Pubitemid 43042140)
65. Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, et al. (2001). Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics 108:883-892. (Pubitemid 32947657)